Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
For more information, please feel free to ask Dr
November 18, 2024
Track your food intake during this transition period to maintain awareness and prevent gradual increases that could stall weight loss
in a GMP compliant facility with foreign & domestic ingredients
Contact us today by phone or book an appointment online
In terms of the magnitude of fat mass reduction in controlled research settings: Semaglutide (GLP-1 alone): ~1015% body weight Tirzepatide (GLP-1 + GIP): ~1622% body weight Retatrutide (GLP-1 + GIP + Glucagon): ~2429% body weight (Phase 2 data) This stepwise increase with each additional receptor target is a remarkable demonstration of pharmacological synergy and has driven enormous interest in the triple-agonist research space
US$ 27.98
US$ 25.50
US$ 26.79
US$ 20.08
